Selected Publications

Chong EA, Tomasulo EB, Barta SK.: 2026 Update on the Management of Diffuse Large B-Cell Lymphoma. Am J Hematol 101(4): 832-863, Apr 2026.

Landsburg DJ, Musoke N, Gentile C, Brooks TR, Nasta SD, Barta SK, Carter JS, Chong EA, Svoboda J, Schuster SJ, Thomas CJ, Tomasulo EB, Cook MR, Morrissette JJD, Caimi PF, Hill BT.: Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma. Leukemia 40(3): 694-697, Mar 2026.

Jiang C, Hoover T, Baron J, Han X, Li B, Gao Y, Kim M, Hubbeling H, Chong EA, Carter J, Svoboda J, Schuster SJ, Landsburg DJ, Nasta SD, Plastaras J, LaRiviere M.: Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma. Int J Part Ther 19: 101304, Feb 2026.

Shan Liu; Puneeth Guruprasad; Ranjani Ramasubramanian; Bhoomi Madhu; Luca Paruzzo; Kecheng Han; Andre Kelly; Alexander Shestov; He N Xu; Alberto Carturan; Chaoting Zhou; Kevin R Amses; Amichay Afriat; Lev Litichevskiy; Jason Lin; Ezra Dubowitz; Neil Tangal; Jing Zhang; Alana McSween; Melody Tan; Federico Stella; Andrew Lee; Siena Nason; Xianxin Hua; Michael Schneider; Madeleine Sleeman; Yunlin Zhang; Giulia Gabrielli; Ziqi Yang; Raymone Pajarillo; Ruchi Patel; Guido Ghilardi; Vrutti Patel; Akshita Joshi; Shunzhou Jiang; Yanqing Jiang; Patrizia Porazzi; Julia C Tchou; Brian Keith; Mingyao Li; Elise Chong; Stephen J Schuster; Michael Milone; Joshua Rabinowitz; Roderick O’Connor; Christoph A Thaiss; Maayan Levy; Marco Ruella: β-Hydroxybutyrate Enhances the Metabolic Fitness of CAR T Cells in Cancer. Cell 2026 Notes: Accepted for publication.

Nikita Dave, Alexandra Dreyfuss, Alison Moskowitz, Joachim Yahalom, Maria Alfaro, Nicole Birrer, Boyu Hu, Rachel Koch, Zachary Frosch, Meryl Colton, Carrie Ho, Behzad Amoozgar, Tatyana Feldman, Abhiraj Saxena, Joanna Rhodes, Ashley Dunton, Nirav Shah, Amelia Mantione, Harper Hubbeling, Michael Lariviere, John Plastaras, Stefan Barta, Jordan Carter, Elise Chong, Michael Cook, Daniel Landsburg, Sunita Dwivedy Nasta, Stephen Schuster, Colin Thomas, Emily Tomasulo, Jakub Svoboda: A multicenter real-world analysis of combined chemotherapy followed by consolidative radiation versus chemotherapy alone in the management of early-stage Hodgkin lymphoma – the HODGKIN25 study. Blood 146(Supplement 1): 3617, Nov 2025.

Luca Paruzzo, Riemke Bouvier, Bria Fulmer, Ivan Cohen, Elise Chong, Jakub Svoboda, Sunita Dwivedy Nasta, Daniel Landsburg, Vrutti Patel, Matthew Ho, Alberto Carturan, Federico Stella, Adam Waxman, Adam Cohen, Dan Vogl, Stefan Barta, Audrey Bochi-Layec, Patrizia Porazzi, Joseph Fraietta, Alfred Garfall, Vijay Bhoj, Edward Stadtmauer, David Porter, James Riley, Peter Merkel, Stephen Schuster, Jordan Carter, Sokratis Apostolidis, Sandra Susanibar-Adaniya, Marco Ruella: Chimeric antigen receptor T-cell therapy in patients with coexisting malignancy and autoimmune disease. Blood 146(Supplement 1): 4543, Nov 2025.

Matthew Frank, David Qualls, Armin Ghobadi, Jordan Gauthier, Michael Tees, Luke Mountjoy, Joseph McGuirk, Sattva Neelapu, Reem Karmali, Iris Isufi, Brian Hill, Craig Sauter, Catherine Diefenbach, Jay Spiegel, Lizamarie Bachier-Rodriguez, Monalisa Ghosh, Nirav Shah, Rahul Lakhotia, Francisco Hernandez-Ilizaliturri, Anuja Abhyankar, Elise Chong, Matthew Schwede, Krish Patel, Olalekan Oluwole, John Baird, Nathan Denlinger, Farrukh Awan, Michael Jain, John Timmerman, Cesar Sanchez, Muthu Kumaran, Jean Yared, Jon Arnason, Ishan Tatake, Usama Gergis, Peter Riedell, Keith Pratz, Nirali Shah: Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial). Blood 146(Supplement 1): 667, Nov 2025 Notes: Oral Presentation, ASH 2025.

Elise Chong, Rachel Lundberg, Matthew Lunning, Stefan Barta, Jordan Carter, Michael Cook, Joseph Fraietta, Daniel Landsburg, Hwan Lee, Sunita Dwivedy Nasta, Jakub Svoboda, Colin Thomas, Christopher D'Angelo, Robert Bociek, Megan Jones, Kaitlin Kennard, Brittany Koch, Peter Michener, Allison Nelson, Alvaro Ordonez, Luca Paruzzo, Marco Ruella, Mark Sellmyer, Ellen Napier, Emeline Chong, Stephen Schuster: Early administration of CD20 x CD3 bispecific antibodies 4-6 weeks after CAR-T infusion for patients with residual or progressive large B cell lymphomas. Blood 146(Supplement 1): 1952, Nov 2025 Notes: Poster Presentation, ASH 2025.

Eliza Hawkes, Joanna Romejko-Jarosinska, Wojciech Jurczak, Sunil Iyengar, Abel Costa, Nimish Shah, Monique Menzies Wojtowicz, Allison Winter, Adam Witkowski, Neil Chua, Ana Jiménez Ubieto, John Kuruvilla, Diego Villa, Chan Cheah, Andre Goy, Elise Chong, Andrew Wood, Rachel Fletcher, Stefanie Meyer, Rebecca Silva, Simon Rule, Michael Wang: Acalabrutinib plus venetoclax and rituximab in patients with treatment-naive (TN) mantle cell lymphoma (MCL): Results from the Phase 2 TrAVeRse study. Blood 146(Supplement 1): 884, Nov 2025 Notes: Oral abstract presentation, ASH 2025.

Nikita Dave, Shannon Gier, Marni Kessler, Miguel Rodriguez, Stefan Barta, Elise Chong, Adam Cohen, Noelle Frey, Saar Gill, Shannon Heck, Elizabeth Hexner, Nasheed Hossain, Shivani Kapur, Daniel Landsburg, Alison Loren, Selina Luger, Mary Ellen Martin, Pashna Munshi, Sunita Dwivedy Nasta, Alexander Perl, David Porter, Stephen Schuster, Edward Stadtmauer, Sandra Susanibar-Adaniya, Jakub Svoboda, Abby Togliatii, Dan Vogl, Adam Waxman, Daniel Wu, Shannon McCurdy: Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy – a prospective, observational Study. Blood 146(Supplement 1): 7189, Nov 2025.